Physician

Robert W Mandal, MD

According to 2025 Medicare claims, Robert Mandal, MD (NPI: 1124012901) practices medical oncology in the Elgin, IL market, with the plurality of this provider's patient population coming from Kane, IL. This provider's primary affiliated billing organization is ILLINOIS CANCER SPECIALISTS (NPI: 1164483913; TIN: 363980044) and primary practice location at 60123-9405.

Mandal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 807 traditional Medicare patients, billed 126,063 HCPCS/CPT codes, and received $1,557,461 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 1,474 prescription claims across 286 beneficiaries totaling $2,919,714 in drug costs, led by Calquence (Acalabrutinib Maleate). DME data shows 121 claims. Open Payments data shows 58 records totaling $1,317. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $344,359 to $2,919,714. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	728	67,858	$890,718
2016	813	84,596	$1,587,127
2017	898	81,916	$1,378,524
2018	956	84,998	$1,178,782
2019	995	131,805	$1,869,721
2020	903	117,473	$1,511,272
2021	923	129,753	$1,812,780
2022	900	113,099	$1,526,198
2023	870	107,637	$1,328,547
2024	807	126,063	$1,557,461

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	109	610	$344,359
2016	115	686	$482,050
2017	137	762	$388,070
2018	139	691	$805,307
2019	174	1,009	$1,451,654
2020	165	910	$1,089,431
2021	198	1,052	$1,733,999
2022	225	1,148	$2,511,337
2023	225	1,250	$2,547,047
2024	286	1,474	$2,919,714

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	50	$18,653
2016	N/R	32	$2,333
2017	N/R	22	$5,301
2018	N/R	N/R	N/R
2019	N/R	35	$3,185
2020	N/R	25	$1,999
2021	N/R	50	$3,438
2022	N/R	15	$540
2023	N/R	62	$6,107
2024	N/R	121	$7,925

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	205	241	$105
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	379	1,235	$69
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	241	434	$63
36415	Insertion of needle into vein for collection of blood sample	391	1,371	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	390	1,414	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Calquence	Acalabrutinib Maleate	27	810	$413,830
Eliquis	Apixaban	202	12,781	$245,611
Kisqali	Ribociclib Succinate	12	336	$209,876
Xarelto	Rivaroxaban	181	11,276	$207,822
Abiraterone Acetate	Abiraterone Acetate	61	1,830	$193,298

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4410	Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, without built-in convexity, larger than 4 x 4 inches, each	N	N/R	11	$1,740
A4385	Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in convexity, each	N	N/R	19	$1,689
A4423	Ostomy pouch, closed; for use on barrier with locking flange, with filter (2 piece), each	N	N/R	13	$1,488
A4394	Ostomy deodorant, with or without lubricant, for use in ostomy pouch, per fluid ounce	N	N/R	23	$1,110
A4407	Ostomy skin barrier, with flange (solid, flexible, or accordion), extended wear, with built-in convexity, 4 x 4 inches or smaller, each	N	N/R	11	$961

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	58	$1,317	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert W. Mandal, MD?

Tedicare shows public-source Medicare data for Robert W. Mandal, MD (NPI 1124012901), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert W. Mandal, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert W. Mandal, MD?

Robert W. Mandal, MD is linked to ILLINOIS CANCER SPECIALISTS (billing NPI 1164483913) in the available physician profile data.

Does Robert W. Mandal, MD have Open Payments data?

Robert W. Mandal, MD has 58 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.